B+
Bull case
30%
Probability
Target price
$295.00
Analysis reference price unavailable
Analysis 2026-10-10 · RankAlpha Sentiment Codex
THC
Tenet HealthcareANYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
45%
Probability
Target price
$265.00
Analysis reference price unavailable
Analysis 2026-10-10 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$225.00
Analysis reference price unavailable
Analysis 2026-10-10 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-10-10
Recent news sentiment (30D)
-26.0
Negative
Company
-
Unavailable
Macro
-26.0
Negative
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+55.6
Score
AI commentary
The Q2 operating picture is constructive but already public, while the deterministic directional prior is neutral. The October 29 report is a dated test, not a known beat. No verified recent analyst revisions, event-linked price reaction, or reliable social, options, short-interest or employee measures were supplied; zero sentiment fields mean unavailable, not measured neutrality. Misidentified news headlines were excluded.
RankAlpha Sentiment Codex - 2026-10-10
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-10-29eventOctober 29 third-quarter results and outlook testMedium impact
Tenet plans to report Q3 results before the market opens on October 29. The decision-relevant test is whether hospital margins, ambulatory earnings and cash flow support its raised 2026 outlook; no Q3 result is yet available [#PR-EARNINGS-2026-10-02] [#SEC-8K-2026-07-23].
2026-10-29catalystPayer-mix and cash-conversion downsideHigh impact
Lower exchange admissions partly offset Q2 operating gains, while first-half adjusted free cash flow declined to $1.422 billion from $1.466 billion a year earlier. Persistence of either pressure at the October report could weaken confidence in full-year delivery [#SEC-8K-2026-07-23].
2026-12-31catalystDelivery against raised 2026 financial outlookHigh impact
After Q2 adjusted EBITDA rose 16.3% year over year, Tenet raised its 2026 adjusted EBITDA outlook to $4.83–$5.03 billion and adjusted free-cash-flow outlook to $2.725–$3.025 billion. Sustained same-facility revenue growth and expense discipline would support the higher outlook, but the July increase is already known [#SEC-8K-2026-07-23].
Recommendation
N/A
No formal recommendation provided.
As of 2026-10-10 • Updated nightlySource: Internal modelMethodology